After adjusting for potential confounders, both reduced and elevated IGF-1 levels were strongly associated with an increased risk of NAFLD compared with patients with normal IGF-1 levels. This evidence concerns the gene IGF1 and metabolic dysfunction-associated steatotic liver disease.